BioPi is developing an implantable bioartificial pancreas that restores natural blood sugar regulation, eliminating the need for insulin injections or immunosuppressive drugs.
BioPi is developing an implantable bioartificial pancreas, designed to restore natural blood sugar regulation for patients with type 1 diabetes.
Our device encapsulates insulin-producing cells inside a protective bioreactor that allows oxygen and nutrients to pass while shielding the cells from the immune system.
